论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Peng C, Zhang J, Hou JQ
Received 10 October 2018
Accepted for publication 27 December 2018
Published 1 February 2019 Volume 2019:11 Pages 1133—1139
DOI https://doi.org/10.2147/CMAR.S190443
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 3
Editor who approved publication: Dr Antonella D'Anneo
Background: Prognosis
for intermediate-risk prostate cancer (PCa) remains variable; therefore, we
aimed to investigate high-risk factors for biochemical recurrence (BCR), and
intermediate-risk PCa using radical prostatectomy to identify patients having
equivalent BCR-free survival rates when compared to high-risk PCa.
Patients and methods: A total
of 441 medical records were analyzed, including those of 169 intermediate-risk
and 272 high-risk PCa patients. Risk factors for time to BCR were tested and
analyzed using Kaplan–Meier survival analysis, log-rank tests, and Cox
proportion hazards models.
Results: In the
intermediate-risk group, prostate-specific antigen density (PSAD) and primary
Gleason pattern were significant preoperative risk factors for BCR. Moreover,
BCR-free survival of patients in the intermediate-risk group with a higher PSAD
(>0.5 ng/mL/cm3) was comparable with that of patients in the
high-risk group (P =0.735). When combining primary Gleason pattern 4 and
3 with PSAD cut-offs 0.3–0.7 ng/mL/cm3, we found that
BCR-free survival of patients in the intermediate-risk group with a primary
Gleason pattern 4 and PSAD >0.3 ng/mL/cm3 was
comparable with that of patients in the high-risk group (P =0.463).
Conclusion: PSAD and
primary Gleason pattern are potential risk factors associated with biochemical
failure in intermediate-risk PCa patients after radical prostatectomy.
Regarding significant differences in prognosis according to PSAD as well as
primary Gleason pattern on biopsy, a subset of the intermediate-risk patients
could be identified with outcomes that were equivalent to that of high-risk
patients.
Keywords: biochemical
recurrence, Gleason grade, intermediate risk, prostate cancer, PSA density